 |
Articles: General Pharma |
Prior Articles
Microbicides Development Programme: design of a phase III trial to measure the efficacy of the vaginal microbicide PRO 2000/5 for HIV prevention
Trials, 10/28/09
Free full text
Issues in the design and interpretation of antifungal drug trials in the critically ill
Current Opinion in Infectious Diseases, 10/28/09 Epocrates Boosts Blackberry Support
HealthDataManagement, 10/28/09 ImmunoGen, Inc. Announces Webcast of Presentation at the Oppenheimer 20th Annual Healthcare Conference
ImmunoGen, Inc., 10/28/09
Free full text
Nabi Biopharmaceuticals to Announce Third Quarter Financial Results on November 2009
Nabi Biopharmaceuticals, 10/28/09
Free full text
BioMarin to Present at the Oppenheimer Healthcare Conference
BioMarin, 10/28/09
Free full text
Cephalon Net Sales Increase 9% and Net Cash from Operations Surpasses $200 Million in the Third Quarter 2009
Cephalon, 10/28/09
Free full text
Fed Advisors to Consider Meaningful Use
HealthDataManagement, 10/28/09 Report: Acquisition Activity Down
HealthDataManagement, 10/28/09 FDA Determines VYVANSE was Properly Granted Five-Year Market Exclusivity
Shire, 10/27/09 Gsk and genmab receive accelerated approval for arzerra
Genmab, 10/27/09
Free full text
Dey Launches and Unveils Next-Generation, Needle-Protected EpiPen(R) (Epinephrine) Auto-Injector with Enhanced Patient-Friendly Features
Mylan, 10/27/09 Genmab achieves milestone in arzerra collaboration
Genmab, 10/27/09
Free full text
New Study on Vyvanse (lisdexamfetamine dimesylate) Capsules CII Shows Administration of Vyvanse Through Two Different Routes Demonstrated a Similar Pharmacokinetic Profile
Shire, 10/27/09 FDA Approves Gardasil to Prevent Genital Warts in Males. Agency Also Approves Bivalent HPV Vaccine for Girls, Young Women
American Family Physician, 10/27/09
Free full text
Gileads Aztreonam for Inhalation Solution to be Reviewed by FDA Anti-Infective Drugs Advisory Committee on December 2009
Gilead, 10/27/09
Free full text
Waste in the U.S. Healthcare System Pegged at $700 Billion in Report from Thomson Reuters
AMN Healthcare, 10/27/09
Free full text
For Parents of Kids with Food Allergies, the Scariest Thing at Halloween is the Trick-or-Treat Bag
Mylan, 10/27/09 FDA Issues Early Communication About Ongoing Safety Review of Weight Loss Drug Orlistat
Gastroenterology, 10/27/09 AstraZeneca partners with Mercy Primary Care Center to help Michigan uninsured
AstraZeneca, 10/27/09
Free full text
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: U.S.Pharmacist, FDA Drug Alerts, Pharmiweb
more...
|
250 Available Pages
|
|
